Investors Can Join The Schall Law Firm In An Inquiry Into Acadia Healthcare Company Inc. For Possible Securities Law Infractions
LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Acadia Healthcare Company, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - ACHC
NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Acadia Healthcare Company, Inc. ("Acadia Healthcare Company, Inc.") (NASDAQ:ACHC) concerning possible violations of federal securities laws. The New York Times published a report on September 1, 2024, entitled "How a Leading Chain of Psychiatric Hospitals Traps Patients.
Bronstein, Gewirtz & Grossman, LLC Encourages Acadia Healthcare Company, Inc.(ACHC) Investors to Inquire about Securities Investigation
NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acadia Healthcare Company, Inc. - ACHC
NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
The Schall Law Firm Is Looking Into Whether Acadia Healthcare Company Inc Violated Securities Laws And Shareholders Are Invited To Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Acadia Healthcare Company, Inc.(ACHC) And Encourages Investors to Reach Out
NEW YORK, NY / ACCESSWIRE / September 4, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.
Why Is Acadia Healthcare (ACHC) Up 9.1% Since Last Earnings Report?
Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock?
Acadia Healthcare Expands Behavioral Health Services in Iowa
ACHC breaks ground on a new behavioral health hospital in Council Bluffs, addressing regional care shortages through a joint venture with Methodist Health System.
5 Hospital Stocks Poised to Benefit From Strong Industry Growth
The Zacks Medical-Hospital industry will gain from increasing admissions and cybersecurity and technological advancements. Companies like HCA, UHS, THC, ACHC and CYH are poised to gain from these trends.
Here's Why Investors Should Hold Acadia (ACHC) Stock for Now
Acadia Healthcare (ACHC) remains well-poised for growth on the back of the solid demand for behavioral healthcare services, continuous pursuit of expansion initiatives and a notable financial position.
Acadia Healthcare (ACHC) Shares Up 12% on Q2 Earnings Beat
Acadia Healthcare's (ACHC) Q2 results reflect higher revenue per patient day and increased patient days. It currently estimates 2024 adjusted EPS within $3.45-$3.65 compared with the earlier view of $3.40-$3.70.
Acadia Healthcare Company, Inc (ACHC) Q2 2024 Earnings Call Transcript
Acadia Healthcare Company, Inc (NASDAQ:ACHC ) Q2 2024 Results Conference Call August 1, 2024 9:00 AM ET Company Participants Patrick Feeley - Head of Investor Relations Chris Hunter - Chief Executive Officer Heather Dixon - Chief Financial Officer Conference Call Participants Whit Mayo - Leerink Partners A.J. Rice - UBS Brian Tanquilut - Jefferies Kevin Fischbeck - Bank of America Ben Hendrix - RBC Capital Markets John Ransom - Raymond James Scott Fidel - Stephens Pito Chickering - Deutsche Bank Andrew Mok - Barclays Sarah James - Cantor Fitzgerald Ryan Langston - TD Cowen Operator Good day, and welcome to Acadia Healthcare's Second Quarter of 2024 Earnings Call.
